A2M

1.42%

$6.23 the a2 milk company limited

Stage 3 on the shelf, page-12

First 12 Last

duty

15,036 Posts.

11/04/16

11:14

Post #: 17470698

Originally posted by Good investments ↑

We have seen that graph many times. Back then a2m share price was 90 cents -$1. Back then our supply from bal and a2m from the pharmacy channel was around 2:1. Bal around 80 tins per month, a2m 40-50 tins per month. Now it's 10:1 . I sincerely hope so far a2m management just give a2m platinum tins to super markets NOT pharmacy. Otherwise, it will be a shock to their sale figures.

If we dont get a profit upgrade soon or in may this shares will be a haven for shorters. Look below, a2m shares have not been heavily shorted.

Bal shorts

Column 1 Column 2 Column 3 Column 4 Column 5 Column 6

1 Date Gross shorts ¹ Issued capital % Capital shorted ² Trade volume ³ Shorts as % of volume

2 Thu 7th Apr, 2016 804,695 96,656,397 0.83% 1,195,644 67.30%

3 Wed 6th Apr, 2016 1,358,243 96,656,397 1.40% 1,846,489 73.56%

4 Tue 5th Apr, 2016 379,974 96,656,397 0.39% 885,488 42.91%

5 Mon 4th Apr, 2016 246,690 96,656,397 0.25% 870,480 28.34%

6 Fri 1st Apr, 2016 281,965 96,656,397 0.29% 832,914 33.85%

7 Thu 31st Mar, 2016 142,362 96,656,397 0.14% 676,699 21.04%

8 Wed 30th Mar, 2016 285,544 96,656,397 0.29% 755,201 37.81%

A2m shorts

Column 1 Column 2 Column 3 Column 4 Column 5 Column 6

1 Date Gross shorts ¹ Issued capital % Capital shorted ² Trade volume ³ Shorts as % of volume

2 Thu 7th Apr, 2016 269,463 711,300,065 0.03% 2,968,388 9.08%

3 Wed 6th Apr, 2016 609,130 711,300,065 0.08% 2,483,070 24.53%

4 Tue 5th Apr, 2016 337,766 711,300,065 0.04% 2,339,036 14.44%

5 Mon 4th Apr, 2016 225,801 711,300,065 0.03% 2,246,618 10.05%

6 Fri 1st Apr, 2016 223,895 711,300,065 0.03% 2,171,232 10.31%

7 Thu 31st Mar, 2016 266,292 708,560,065 0.03% 2,226,168 11.96%

8 Wed 30th Mar, 2016 510,568 708,560,065 0.07% 2,458,421 20.77%

Expand

mate ya don't own ya just here strring ...& you seem to be the only one with supply issues with A2 ...I said long time ago as well BAL is slipping in sales ..have over supply issues

A2M Price at posting: $1.71 Sentiment: Buy Disclosure: Held

3 Upvote

0 Great analysis

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 40 more messages in this thread...

First 12 Last

Add A2M (ASX) to my watchlist

(20min delay)
Last $6.23		Change -0.090(1.42%)		Mkt cap ! $4.510B

Open	High	Low	Value	Volume
$6.30	$6.31	$6.17	$6.785M	1.089M

Buyers (Bids)

No.	Vol.	Price($)
1	5458	$6.23

Sellers (Offers)

Price($)	Vol.	No.
$6.24	13490	1

View Market Depth

No.	Vol.	Price($)
2	5025	6.210
1	484	6.200
1	1000	6.150
5	9029	6.100
1	1652	6.050

Price($)	Vol.	No.
6.260	1604	1
6.280	10000	1
6.300	1750	1
6.320	700	1
6.350	2000	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

A2M (ASX) Chart

Stage 3 on the shelf, page-12

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6
1	Date	Gross shorts ¹	Issued capital	% Capital shorted ²	Trade volume ³	Shorts as % of volume
2	Thu 7th Apr, 2016	804,695	96,656,397	0.83%	1,195,644	67.30%
3	Wed 6th Apr, 2016	1,358,243	96,656,397	1.40%	1,846,489	73.56%
4	Tue 5th Apr, 2016	379,974	96,656,397	0.39%	885,488	42.91%
5	Mon 4th Apr, 2016	246,690	96,656,397	0.25%	870,480	28.34%
6	Fri 1st Apr, 2016	281,965	96,656,397	0.29%	832,914	33.85%
7	Thu 31st Mar, 2016	142,362	96,656,397	0.14%	676,699	21.04%
8	Wed 30th Mar, 2016	285,544	96,656,397	0.29%	755,201	37.81%

Stage 3 on the shelf, page-12

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News